Moderna (CHIX:0QFD) Total Liabilities: €3,529 Mil (As of Mar. 2026)


CHIX:0QFD Moderna Inc CHIX:0QFD
20 GF Score
Price €63.59
GF Value €20.82
! 7 Warning Signs
View Full Analysis

What is Moderna Total Liabilities?

Moderna CHIX:0QFD +48.91% 20 Total Liabilities is €3,529 Mil as of Mar. 2026. GuruFocus rates CHIX:0QFD with a GF Score™ of 20/100 and a GF Value™ of €20.82. The stock has 7 warning signs investors should review.

Moderna's Total Liabilities for the quarter that ended in Mar. 2026 was €3,529 Mil.

Moderna's quarterly Total Liabilities increased from Sep. 2025 (€2,389.86 Mil) to Dec. 2025 (€3,149.55 Mil) and increased from Dec. 2025 (€3,149.55 Mil) to Mar. 2026 (€3,529.20 Mil).

Moderna's annual Total Liabilities declined from Dec. 2023 (€4,192.52 Mil) to Dec. 2024 (€3,095.16 Mil) but then increased from Dec. 2024 (€3,095.16 Mil) to Dec. 2025 (€3,149.55 Mil).

Moderna Total Liabilities Historical Data

* Premium members only.

The historical data trend for Moderna's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Moderna Total Liabilities Chart

Moderna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9,313.74 6,357.84 4,192.52 3,095.16 3,149.55

Moderna Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,440.15 2,263.74 2,389.86 3,149.55 3,529.20
CHIX:0QFD
20GF Score
Moderna Inc CHIX:0QFD
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Moderna Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Moderna's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1696.898+(1078.602+30.744
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+130.662+0+212.646)
=3,150

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=10536.652-7387.1
=3,150

Moderna's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2071.675+(1079.52+25.95
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+133.21+0+212.646)
=3,529

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=9937.12-6407.92
=3,529

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €3,529 Mil mean?
Moderna (CHIX:0QFD) has a Total Liabilities of €3,529 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Moderna and its competitors.
Is Moderna's Total Liabilities too high?
Moderna's current Total Liabilities is €3,529 Mil. Overall, Moderna has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Moderna's Total Liabilities compare to RPRX and ROIV?
Moderna's Total Liabilities of €3,529 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Moderna and its competitors. Moderna's current Total Liabilities is €3,529 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Moderna stock overvalued right now?
Moderna (CHIX:0QFD) has a current Total Liabilities of €3,529 Mil. The stock's GF Value™ is €20.82, compared to a current price of €63.59 — trading 205.4% above its estimated fair value. The current Total Liabilities is €3,529 Mil. Moderna's overall GF Score™ is 20/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Moderna (CHIX:0QFD), the current Total Liabilities is €3,529 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Moderna (CHIX:0QFD) Overvalued in 2026?

Based on GuruFocus' analysis, Moderna stock appears to be overvalued. The current stock price of €63.59 is trading 205.4% above its estimated GF Value™ of €20.82.

Key valuation signals for CHIX:0QFD:

  • Total Liabilities: €3,529 Mil
  • GF Value™: €20.82 vs. price of €63.59 (205.4% above fair value)
  • GF Score™: 20/100 with 7 warning signs

No single metric tells the full story. See the CHIX:0QFD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Moderna Business Description

Address 325 Binney Street, Cambridge, MA, USA, 02142
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
20GF Score

Get the complete analysis for CHIX:0QFD

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€63.59
Price
€20.82
GF Value